Arrhythmia
- Survivors of sudden cardiac death: a rational approach to evaluation and therapy of patients surviving ventricular fibrillation
A strategy for identifying underlying disease, stratifying the risk of recurrence, and formulating specific therapy in these patients, at high risk for life-threatening ventricular tachyarrhythmias.
- Indications for electrophysiologic study in patients with ventricular arrhythmias
An analysis of current guidelines for the use of electrophysiologic study, and a look at practical applications.
- Moricizine: pharmacodynamic, pharmacokinetic, and therapeutic profile of a new antiarrhythmic
This agent appears to be well tolerated, with a low incidence of both short-term and long-term side effects. However, more clinical experience is needed to better define its antiarrhythmic role.